Eunice Spengler Selected Research

Mifepristone (RU 486)

1/2023

Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eunice Spengler Research Topics

Disease

4	Breast Neoplasms (Breast Cancer) 01/2023 - 02/2020
2	Neoplasms (Cancer) 12/2021 - 02/2020
1	Thyroid Neoplasms (Thyroid Cancer) 12/2023
1	Goiter 12/2023
1	Lymphatic Metastasis 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022

Drug/Important Bio-Agent (IBA)

3	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 02/2020
3	Phenobarbital (Luminal)FDA Link 01/2023 - 02/2020
2	Protein Isoforms (Isoforms)IBA 01/2023 - 01/2022
1	trans-crotonin (CTN)IBA 12/2023
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 12/2023
1	Therapeutic UsesIBA 01/2023
1	Mifepristone (RU 486)FDA Link 01/2023
1	Progestins (Progestagens)IBA 01/2022
1	LigandsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	B7-H1 AntigenIBA 12/2021
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 02/2020
1	AndrogensIBA 02/2020
1	Estrogen Receptor alphaIBA 02/2020
1	Hormones (Hormone)IBA 02/2020
1	Estrogen ReceptorsIBA 02/2020
1	Androgen Receptors (Androgen Receptor)IBA 02/2020

Therapy/Procedure

1	Thyroidectomy 12/2023